Friday, July 17, 2015

7 16 2015 BMP2 qPCR

Today I started running more targets that may be of interest due expected changes in expression. Here I explore BMP2 which is expected to have decreased expression due to exposure to increased temperatures. 

Primers:

1640BMP-2_FWDTGAAGGAACGACCAAAGCCAJH5/21/20152055O.luridaBone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A)P12643
1639BMP-2_REVTCCGGTTGAAGAACCTCGTGJH5/21/20152055O.luridaBone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A)P12643

Reagent Table:
VolumeReactions X116
Ssofast Evagreen MM101160
FWD Primer0.558
REV Primer0.558
1:9 cDNA9
  1. Added reagents from greatest to least volume
  2. Vortexed
  3. Centrifuged briefly
  4. Pipetted 11 ul Master Mix to each tube
  5. Pipetted 9 ul of 1:9 cDNA each column using a channel pipetter
  6. Centrifuged plate at 2000 rpm for 1 minute
  7. Ran Program Below
Program:
StepTemperatureTime
Initiation95 C10 min
Elongation95 C30 sec
60 C1 min
Read
72 C30 sec
Read
Repeat Elongation 39 times
Termination95 C1 min
55 C1 sec
Melt Curve Manual ramp 0.2C per sec Read 0.5 C55 - 95 C30 sec
21 C10 min
End
Plate Layout:
1234567
DNased 42215 HC1DNased 42215 NC1DNased 42215 SC1DNased 42215 HT1 1DNased 42215 NT1 1DNased 42215 ST1 1NTC
DNased 42215 HC2DNased 42215 NC2DNased 42215 SC2DNased 42215 HT1 2DNased 42215 NT1 2DNased 42215 ST1 2NTC
DNased 42215 HC3DNased 42215 NC3DNased 42215 SC3DNased 42215 HT1 3DNased 42215 NT1 3DNased 42215 ST1 3NTC
DNased 42215 HC4DNased 42215 NC4DNased 42215 SC4DNased 42215 HT1 4DNased 42215 NT1 4DNased 42215 ST1 4NTC
DNased 42215 HC5DNased 42215 NC5DNased 42215 SC5DNased 42215 HT1 5DNased 42215 NT1 5DNased 42215 ST1 5
DNased 42215 HC6DNased 42215 NC6DNased 42215 SC6DNased 42215 HT1 6DNased 42215 NT1 6DNased 42215 ST1 6
DNased 42215 HC7DNased 42215 NC7DNased 42215 SC7DNased 42215 HT1 7DNased 42215 NT1 7DNased 42215 ST1 7
DNased 42215 HC8DNased 42215 NC8DNased 42215 SC8DNased 42215 HT1 8DNased 42215 NT1 8DNased 42215 ST1 8
Results:

All samples
NTCs

These curves look okay but I'm not 100% okay with the bumpy melt curve. I ran an ANOVA and Tukey's HSD to produce significant differences for analysis. To improve the analysis and the boxplot/expression bar graph, I adjusted the data set by removing NA's from the data. 

Adjusted Expression Graph
There's clearly some difference in expression as the appears to be chunks of the population that have much lowered expression. 

Adjusted ANOVA/Tukey's HSD
Call:
   aov(formula = expression ~ Pop + Treat + Pop:Treat, data = rep2res2)

Terms:
                         Pop        Treat    Pop:Treat    Residuals
Sum of Squares  3.918260e-22 9.723005e-21 1.573763e-21 9.279358e-21
Deg. of Freedom            2            1            2           38

Residual standard error: 1.56267e-11
Estimated effects may be unbalanced
> TukeyHSD(fit)
  Tukey multiple comparisons of means
    95% family-wise confidence level

Fit: aov(formula = expression ~ Pop + Treat + Pop:Treat, data = rep2res2)

$Pop
             diff           lwr          upr     p adj
N-H   0.4224591
S-H   0.8174685
S-N  0.8189700

$Treat
             diff           lwr           upr p adj
T-C  2e-07

$`Pop:Treat`
                 diff           lwr           upr     p adj
N:C-H:C   0.6961640
S:C-H:C  0.9298189
H:T-H:C  0.0032438
N:T-H:C  0.0048368
S:T-H:C  0.2481527
S:C-N:C  0.1806352
H:T-N:C  0.0000405
N:T-N:C  0.0000732
S:T-N:C  0.0140727
H:T-S:C  0.0411016
N:T-S:C  0.0532668
S:T-S:C  0.7297433
N:T-H:T   1.0000000
S:T-H:T   0.7788719
S:T-N:T   0.7991437

There are significant differences between the Treatment and Control. There's also several significant differences between pop-treatment groups. Everything in bold is a significant difference. Clearly the Dabob treatment is different from the Dabob control, the Fidalgo treatment is different from Fidalgo control.

Adjusted Expression Boxplot

You can see the differences very well with the boxplot above. 

You can see the raw data here

No comments:

Post a Comment